Medistep Healthcare Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | August 8, 2025 to August 12, 2025 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Issue Price | ₹ 43 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 37,44,000 shares (aggregating up to ₹ 16.10 Cr) |
| Reserved for Market Maker | 1,89,000 shares (aggregating up to ₹ 0.8127 Cr) Nirman Share Brokers Private Limited |
| Net Offered to Public | 35,55,000 shares (aggregating up to ₹ 15.29 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,04,65,546 shares |
| Share Holding Post Issue | 1,42,09,546 shares |
About Medistep Healthcare Limited IPO
Medistep Healthcare Limited IPO is of ₹16.10 crores, consisting of 37.44 lakh fresh equity shares. The IPO is to be subscribed publicly between 8th August, 2025 to 12th August, 2025. Retail investors can apply for a minimum lot size of 6,000 shares, which will be of ₹2,58,000 and HNIs can apply for 9,000 shares of ₹3,87,000. Allotment will be completed on 13th August 2025, with the shares likely to be listed on the NSE SME platform on 18th August 2025.
Company Background
Established in 2023 in Ahmedabad, Gujarat, Medistep became a dynamic healthcare and pharmaceutical corporation that offers a vast variety of products from sanitary pads to nutraceutical products and more. The company is strongly focused on providing innovative, high-quality health care solutions. Medistep works in a business that’s a combination of both manufacturing and distribution of products and services offered by the company. With a strong sense of quality control, customer service and expansion plans, the company has rapidly placed itself as a notable brand in the healthcare industry.
Operations & Product Range
Facility and Services
The company currently operates its manufacturing facility, which is located in the Kheda district of Gujarat and covers approximately 371.61 square meters. The company has a strong focus on manufacturing and trading a variety of healthcare products, which include the production of sanitary pads under the brand name Drystep and energy powders under the brand name Vitastep. Along with that, Medistep also manufactures nutraceutical, pharmaceutical, Intimate care and surgical products.
Brand and Market Presence
Medistep, along with its key in-house brands by the name of Drystep and Vitastep, has established a good presence in both domestic and international healthcare markets. The company has a strong regional foothold in Gujarat and aims for a wide market presence. It currently distributes various products to well-known clients like Astha Multispeciality Hospital, Ocean Multispeciality Hospital, Rudraksha Institute of Medical Sciences, Sadguru Hospital, Unity Hospital and Sunrise Hospital.
Revenue Channels
A revenue growth from ₹39.07 crore in FY24 to ₹49.65 crore in FY25 was witnessed by Medistep. The company gains its revenue primarily from two main sources -
- 1. The company gains a major part of its revenue through its manufacturing of sanitary pads under Drystep and energy powders under Vitastep, which cater to the healthcare and wellness sectors.
- 2. Medistep also earns revenue through the distribution of a diverse range of nutraceutical, pharmaceutical, surgical and personal care products, which helps in the expansion of the company’s market presence.
Management & Shareholding
Promoters and Shareholders
Medistep Healthcare Limited IPO is promoted by Mr. Girdhari Lal Pratap, Mr. Dabhi Vipul Gobarbhai, Ms. Prajapati Hetalben Girdharilal and Mr. Jagdish Prajapati. The promoters have approximately 93.62% stake in the company and are expected to reduce to 68.96% after the company’s IPO listing on 8th August.
Board Members
The board group of Medistep Healthcare Limited includes various managerial experts who have a good amount of experience in the healthcare industry, like, Girdhari Lal Prajapat, who is the Managing Director of Medistep, as well as Vipul Gobarbhai Dabhi, Anandbhai Jitendrabhai Khoda, Kapilbhai Raysinhbhai Dodiya and Hetalben Shankarlal Prajapati, who are the Directors of the company.
Objectives of Medistep Healthcare Limited IPO
The primary objective of the IPO is to provide funding for the purchase of new machinery and plant for the existing facility in order to support the expansion plans for the company. Some part of the proceeds will be used to provide capital support for working requirements, as well as to fulfill the general corporate functioning of the company.
Conclusion
Medistep Healthcare Limited IPO provides a chance for investment in a swiftly growing healthcare and wellness products manufacturer. The company has a wide and well-established client base, domestically and internationally and is looking forward to expanding its footprint globally. It caters to clients like Sadguru Hospital, Sunrise Hospital, Rudraksha Institute of Medical Sciences and many more. Medistep Healthcare Limited IPO will provide support for the company’s plan to enhance its presence in the healthcare market and increase the brand value of the corporation.
Medistep Healthcare Limited IPO Financial Information
Latest Revenue
49.66
₹ Crore
Profit After Tax
4.14
₹ Crore
Net Worth
16.83
₹ Crore
Total Borrowing
0.64
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 22.99 | 49.66 | 4.14 | 16.83 | 0.64 | ||||
| 31 Mar 2024 | 15 | 32 | 3 | 12 | 0.33 | ||||
| 31 Mar 2023 | 14.66 | 27.74 | 0.92 | 1.07 | 0.53 | ||||
| Amount in ₹ Crore | |||||||||
Medistep Healthcare Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 0.53 |
| ROCE | 38.91% |
| RoNW | 29.06% |
| PAT Margin | 8.35% |
| EBITDA Margin | 11.27% |
| Price to Book Value | 2.67 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 3.96 | 3 |
| P/E (x) | 10.86 | 15 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
1. The company is guided to new heights by an experienced team of managers and directors who ensure the high growth of Medistep.
2. Medistep ensures optimum use of resources and maintains a strong check on the quality supply as well as the application of cost-saving strategies in the company.
3. It offers a large portfolio of products varying from nutraceutical, pharmaceutical, healthcare and even personal hygiene.
Download regulatory filings
Medistep Healthcare Limited IPO Timeline
| IPO Open Date | Fri, Aug 8, 2025 |
| IPO Close Date | Tue, Aug 12, 2025 |
| Tentative Allotment | Wed, Aug 13, 2025 |
| Initiation of Refunds | Thu, Aug 14, 2025 |
| Credit of Shares to Demat | Thu, Aug 14, 2025 |
| Tentative Listing Date | Mon, Aug 18, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 12, 2025 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 6,000 | ₹2,58,000 |
| Individual investors (Retail) (Max) | 2 | 6,000 | ₹2,58,000 |
| HNI (Min) | 3 | 9,000 | ₹3,87,000 |